Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and Leukemia, Myeloid, Acute

1-(carboxymethylthio)tetradecane has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berge, R; Erikstein, BS; Gjertsen, BT; McCormack, E; Schwede, F; Tronstad, KJ1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Leukemia, Myeloid, Acute

ArticleYear
Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB.
    Leukemia research, 2010, Volume: 34, Issue:1

    Topics: Animals; Chromatography, High Pressure Liquid; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Drug Synergism; Enzyme Activators; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Peroxisome Proliferator-Activated Receptors; Rats; Sulfides

2010